Sign in

CIK 0001658551 · Non-accelerated filer<br>Smaller reporting company

Amylyx Pharmaceuticals, Inc.

Sign in to watch
Ticker
AMLX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
464600503
Phone
617-682-0917
Business address
55 CAMBRIDGE PARKWAY, SUITE 6W, CAMBRIDGE, MA, 02142
  1. 144 Insider Sale of Securities
  2. SCHEDULE 13G/A Stake Statement of Beneficial Ownership
  3. 10-Q Report Quarterly Report
  4. 8-K Event Results of operations
  5. SCHEDULE 13G Stake Statement of Beneficial Ownership
  6. SCHEDULE 13G Stake Statement of Beneficial Ownership
  7. SCHEDULE 13G Stake Statement of Beneficial Ownership
  8. 4 Derivatives Options or other derivatives
  9. 4 Derivatives Options or other derivatives
  10. 4 Derivatives Options or other derivatives
  11. 4 Derivatives Options or other derivatives
  12. 4 Derivatives Options or other derivatives
  13. 8-K Event Shareholder vote results
  14. 4 Gift Chief Legal Officer gave 1,000 shares (gift)
  15. SCHEDULE 13G/A Stake Statement of Beneficial Ownership
  16. SCHEDULE 13G/A Stake Statement of Beneficial Ownership
  17. SCHEDULE 13G Stake Statement of Beneficial Ownership
  18. 10-Q Report Quarterly Report
  19. 8-K Event Results of operations
  20. ARS Other Annual Report to Security Holders

Page 7 of 23 · 446 filings